Children's Hospital Colorado

Q: Advances and Answers in Pediatric Health

Q: is a quarterly magazine where we highlight some of our groundbreaking research and innovations, featuring the many ways our clinicians work together and across specialties to continually improve patient care and outcomes.

Read some of the latest articles from our current issue. You can also access full digital versions of all Q: magazine issues at the bottom of the page.

It starts with a Q:

Like the kids we treat at Children's Hospital Colorado, we're creating a culture that continuously inspires curiosity. Doing so unlocks a new realm of pediatrics — one that swaps insular science and medicine for collaborative, progressive approaches to accelerating discovery. 

 A unique and strong partnership with University of Colorado Anschutz Medical Campus provides fresh perspectives and invaluable expertise, as do our relationships with national and international research consortiums, industry partners and other children's hospitals.

test tubes

Data sharing and collaboration in the fight against COVID-19

Faced with uncertainty about a novel disease, researchers developed three collaborative data platforms to better understand COVID-19, its impact and possible treatment options.

Q: How can data science impact the ways we treat and understand COVID-19?

Doctor scanning back of patient's neck

Epidermolysis bullosa program

Epidermolysis bullosa is a family of rare genetic conditions that causes fragility of the skin and mucosal membranes, leading to very painful blistering and scarring at even the slightest trauma. While there isn’t a cure, researchers are hopeful about two promising treatments.

Q: What are the latest advances in treatment for children with a rare skin disease? 

X-ray of S-ICD

Discoveries in subcutaneous implantable cardioverter defibrillators (S-ICDs)

Having a permanent device implanted in your body is a big step for anyone. While S-ICDs are less invasive, researchers set out to determine how safe and effective they are among pediatric patients.

Q: How effective are S-ICDs as the first line of therapy for pediatric patients?

DNA strand

Gene therapy for cystic fibrosis

Advanced genetic testing tools allow us to diagnose genetic conditions like cystic fibrosis before birth. Now, researchers are testing whether they can treat conditions like this through in utero gene-based therapies.

Q: What if medicine could not only diagnose a genetic mutation in utero, but intervene?

X-ray of scoliosis

The role of epigenetics in adolescent idiopathic scoliosis (AIS)

A new study, using the largest known set of identical twins with AIS, worked to better understand whether and how epigenetic, or environmental, factors play a role in disease onset.

Q: What can studying identical twins reveal about the potential role of epigenetics in adolescent idiopathic scoliosis?

brain images

Novel treatments in neuro-oncology

Three neuro-oncologists are part of a team of researchers and clinicians united under one goal: finding new solutions to some of the most devastating pediatric cancers.

Q: Can collaboration propel treatment options for central nervous system tumors to new heights?

Recent issues of Q:

Access full digital versions of Q: magazine to learn how our clinicians work together and across specialties to continually improve patient care and outcomes.

Past issues of Q:

Stay informed

Get the latest updates on Twitter

Advancements in pediatric research, clinical innovation and news Follow Us